ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

LANADELUMABUM

Active substance (INN) · ATC B06AC05 · 2 products authorised in Romania

◀ Back

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

Code	Protocol	Status	Role	Sublist	GP
B06AC05	LANADELUMABUM	In force	medicine of the protocol	C2-P6.22	YES

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand name	Form	Strength	Holder	ATC	Rx
TAKHZYRO 150 mg	SOL INJ. IN SERINGA PREUMPLUTA	150mg	TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BRANCH - IRLANDA	B06AC05	PR
TAKHZYRO 300 mg	SOL. INJ. IN SERINGA PREUMPLUTA	300mg	TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BR - IRLANDA	B06AC05	PR
TAKHZYRO 300 mg	SOL. INJ. IN STILOU INJECTOR PREUMPLUT	300mg	TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BR - IRLANDA	B06AC05	PR

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.